Search Results - "Lopalco, G"
-
1
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast
Published in Clinical and experimental immunology (01-08-2020)“…Summary The pathogenesis of psoriatic arthritis (PsA) involves several pathways, including the CD40/CD40L signaling which promotes the release of multiple…”
Get full text
Journal Article -
2
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity
Published in Clinical and experimental immunology (11-12-2023)“…Abstract Pentraxin-3 (PTX3) is a component of humoral innate immunity with essential functions both in promotion and resolution of inflammation. We aimed to…”
Get full text
Journal Article -
3
Disease activity assessment for juvenile idiopathic arthritis in transitional care
Published in Reumatismo (24-06-2024)“…The indices to measure disease activity of chronic arthritis in adulthood and childhood are different. Therefore, assessing the status of the disease in young…”
Get full text
Journal Article -
4
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry
Published in Clinical rheumatology (01-09-2021)“…The objective is to evaluate the effectiveness of a spacing strategy of bDMARDs in a cohort of selected patients in disease remission or low-disease activity…”
Get full text
Journal Article -
5
Efficacy and safety of abatacept in a patient with rheumatoid arthritis and concomitant Staphylococcus aureus osteomyelitis
Published in Clinical and experimental rheumatology (01-11-2015)Get full text
Journal Article -
6
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy
Published in Reumatismo (17-03-2014)“…Despite lacking of international guidelines about the management of patients with occult hepatitis B virus infection (OBI) starting TNF-α blockers, there is…”
Get full text
Journal Article -
7
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman
Published in Reumatismo (30-06-2015)“…A peculiar coexistence of axial spondyloarthritis and ischemia of the feet and the fourth finger of the left hand in a young woman, who was a heavy smoker, is…”
Get full text
Journal Article -
8
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease
Published in Pediatric rheumatology online journal (28-09-2015)Get full text
Journal Article -
9
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature
Published in Clinical and experimental rheumatology (01-01-2021)“…Adult-onset Still's disease (AOSD) is a rare, inflammatory disease of unknown aetiology, generally affecting young adults and requiring immunosuppressive…”
Get more information
Journal Article -
10
287. TOCILIZUMAB TREATMENT FOR LARGE VESSELS VASCULITIS: REAL LIFE PRELIMINARY EXPERIENCES
Published in Rheumatology (Oxford, England) (01-03-2019)Get full text
Journal Article -
11
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis
Published in Clinical and experimental rheumatology (01-07-2019)“…The aim of the study was to evaluate the efficacy of golimumab (GOL) and certolizumab pegol (CZP) as additional treatment options for the treatment of uveitis…”
Get full text
Journal Article -
12
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors
Published in Clinical and experimental rheumatology (01-01-2023)“…Scanty data on the anti- SARS-CoV-2 IgG level decay after two-dose BNT162b2 vaccination have been published in patients with psoriatic arthritis (PsA) on TNF…”
Get more information
Journal Article -
13
Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus
Published in Clinical and experimental rheumatology (01-01-2021)Get more information
Journal Article -
14
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study
Published in Clinical and experimental rheumatology (01-11-2020)“…To evaluate the efficacy of tumour necrosis factor (TNF)-α inhibitors in refractory non-infectious scleritis. We carried out a retrospective study assessing…”
Get more information
Journal Article -
15
Safety profile of anakinra in the management of rheumatologic, metabolic and autoinflammatory disorders
Published in Clinical and experimental rheumatology (01-05-2016)“…Anakinra is a biologic response modifier that competitively antagonises the biologic effects of interleukin-1, the ancestor pleiotropic proinflammatory…”
Get full text
Journal Article -
16
Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection
Published in Clinical and experimental rheumatology (01-03-2016)Get full text
Journal Article -
17
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study
Published in Clinical and experimental rheumatology (01-03-2023)“…Rituximab (RTX) is an anti-CD20 chimeric monoclonal antibody recommended as off-label treatment in patients with idiopathic inflammatory myopathies (IIM). The…”
Get more information
Journal Article -
18
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey
Published in Clinical and experimental rheumatology (01-09-2019)“…Good drug survival of tumour necrosis factor inhibitors (TNFi) has been shown in axial spondyloarthritis (axSpA) patients treated in real-life setting…”
Get full text
Journal Article -
19
New therapeutic solutions for Behçet's syndrome
Published in Expert opinion on investigational drugs (02-07-2016)“…Behçet's syndrome (BS) is a systemic inflammatory disorder characterized by a wide range of potential clinical manifestations with no gold-standard therapy…”
Get more information
Journal Article -
20
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet's Syndrome and Psoriatic Arthritis
Published in International journal of molecular sciences (16-05-2023)“…Behçet's syndrome (BS) is a rare systemic vasculitis characterized by different clinical manifestations. As no specific laboratory tests exist, the diagnosis…”
Get full text
Journal Article